{"denoms":[{"counts":[{"groupId":"BG000","value":"28"}],"units":"Participants"}],"groups":[{"description":"See Detailed Description\n\nCyclosporine: Given IV or PO\n\nDasatinib: Given PO\n\nFludarabine Phosphate: Given IV\n\nImatinib Mesylate: Given PO\n\nMycophenolate Mofetil: Given PO\n\nNilotinib: Given PO\n\nNonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Undergo nonmyeloablative allogeneic PBSC transplantation\n\nPeripheral Blood Stem Cell Transplantation: Undergo allogeneic PBSC transplantation\n\nTherapeutic Allogeneic Lymphocytes: Given IV\n\nTotal-Body Irradiation: Undergo TBI","id":"BG000","title":"Treatment (Allogeneic Nonmyeloablative HSCT)"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"26"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"2"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"33.8","upperLimit":"69.8","value":"57.6"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"19"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"28"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}